What sizes are available for C-C chemokine receptor type 5 CCR5 Rabbit Polyclonal Antibody?

C-C chemokine receptor type 5 CCR5 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

C-C chemokine receptor type 5 CCR5 Rabbit Polyclonal Antibody

Q: What is the catalog number for C-C chemokine receptor type 5 CCR5 Rabbit Polyclonal Antibody?

The catalog number for C-C chemokine receptor type 5 CCR5 Rabbit Polyclonal Antibody is orb107615.

Anti-C-C chemokine receptor type 5 CCR5 Antibody. Tested in Flow Cytometry, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

C-C chemokine receptor type 5; C-C CKR-5; CC-CKR-5; CCR-5; CCR5; CHEMR13; HIV-1 fusion coreceptor; CD195; CCR5; CMKBR5

UniProt

P51681

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence in the middle region of human CCR5.

Target

C-C chemokine receptor type 5

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Immunology & Inflammation, Infectious Disease & Virology, Microbiology, Neuroscience, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human Flow Cytometry (Fixed), 1-3μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

40 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.